# Tetrandrine Tablets Used in Hospitalized Adults With COVID-19

> **NCT05697029** · PHASE4 · WITHDRAWN · sponsor: **Peking University Third Hospital**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Tetrandrine

## Key facts

- **NCT ID:** NCT05697029
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12-31
- **Primary completion:** 2025-12-12
- **Final completion:** 2025-12-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to the lack of funding from the sponsor, the research drug and placebo cannot be obtained.
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05697029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05697029, "Tetrandrine Tablets Used in Hospitalized Adults With COVID-19". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05697029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*